InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Discover the detailed record of transactions filed by Ellis Andrea, Director. Officer active across 1 company, notably BridgeBio Pharma, Inc.. Cumulatively, 4 disclosures have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €92k. Activity tracked since 15 March 2022. The latest transaction was disclosed on 14 April 2025 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
4 of 4 declarations
Andrea Ellis serves as a Board Member at BridgeBio Pharma, Inc. In this role, she contributes to overseeing the company's activities and developing its strategy. With a strong background in the pharmaceutical sector, Andrea Ellis brings valuable insights into market challenges and innovation opportunities. She is committed to ensuring that BridgeBio Pharma adheres to corporate governance standards and supports its sustainable development.